<DOC>
	<DOCNO>NCT01492725</DOCNO>
	<brief_summary>Patients present emergency department acute ischaemic stroke , eligible standard intravenous tPA therapy within 4.5 hour stroke onset assess `` dual target '' major vessel occlusion mismatch determine eligibility randomisation trial . If patient give informed consent randomise 50:50 use central computerised allocation intra-arterial clot retrieval IV tPA IV tPA alone . The trial prospective , randomised , open-label , blind endpoint ( PROBE ) design .</brief_summary>
	<brief_title>Extending Time Thrombolysis Emergency Neurological Deficits - Intra-Arterial</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>1 . Patients present anterior circulation acute ischaemic stroke eligible use standard criterion receive IV tPA within 4.5 hour stroke onset 2 . Patient , family member legally responsible person depend local ethic requirement give informed consent 3 . Patient‟s age ≥18 year 4 . Intraarterial clot retrieval treatment commence ( groin puncture ) within 6 hour stroke onset . Imaging inclusion criterion Dual target : 5 . Arterial occlusion CTA MRA ICA , M1 M2 6 . Mismatch Using CT MRI Tmax &gt; 6 second delay perfusion volume either CTrCBF DWI infarct core volume . ) Mismatch ratio great 1.2 , b ) Absolute mismatch volume great 10 ml , . c ) Infarct core lesion volume le 70mL 1 . Intracranial haemorrhage ( ICH ) identify CT MRI 2 . Rapidly improve symptom discretion investigator 3 . Prestroke mRS score ≥ 2 ( indicate previous disability ) 4 . Inability access cerebral vasculature opinion neurointerventional team 5 . Contra indication image MR contrast agent 6 . Participation investigational study previous 30 day 7 . Any terminal illness patient would expect survive 1 year 8 . Any condition , judgment investigator could impose hazard patient study therapy initiate affect participation patient study . 9 . Pregnant woman 10 . Previous stroke within last three month 11 . Recent past history clinical presentation ICH , subarachnoid haemorrhage ( SAH ) , arteriovenous ( AV ) malformation , aneurysm , cerebral neoplasm . At discretion Investigator . 12 . Current use oral anticoagulant prolong prothrombin time ( INR &gt; 1.6 ) 13 . Use heparin , except low dose subcutaneous heparin , previous 48 hour prolong activate partial thromboplastin time exceed upper limit local laboratory normal range . 14 . Use glycoprotein IIb IIIa inhibitor within past 72 hour . Prior use single dual agent oral platelet inhibitor ( clopidogrel and/or lowdose aspirin ) permit . 15 . Clinically significant hypoglycaemia . 16 . Uncontrolled hypertension define blood pressure &gt; 185 mmHg systolic &gt; 110 mmHg diastolic least 2 separate occasion least 10 minute apart , require aggressive treatment reduce blood pressure within limit . The definition `` aggressive treatment '' leave discretion responsible Investigator . 17 . Hereditary acquire haemorrhagic diathesis 18 . Gastrointestinal urinary bleeding within precede 21 day 19 . Major surgery within precede 14 day pose risk opinion investigator . 20 . Exposure thrombolytic agent within previous 72 hr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>